Brian Wiley
Corporate Officer/Principal bij PORTAGE BIOTECH INC.
Vermogen: - $ op 31-03-2024
Profiel
Brian Wiley is the founder of Boston Bioconsulting LLC, which was founded in 2018.
He held the title of Principal at the company.
Currently, Mr. Wiley is the Chief Business Officer at Portage Biotech, Inc. since 2022 and the Senior VP-Corporate Development & Strategy at Aprea Therapeutics, Inc. since 2023.
In his former positions, Mr. Wiley worked as a Senior Director-Oncology Marketing at Celgene Corp., Director-Market Planning at Millennium Pharmaceuticals, Inc., Senior Director-Marketing & Business Development at Gloucester Pharmaceuticals, Inc., and Chief Commercial Officer at NewLink Genetics Corp.
from 2016 to 2018.
He also worked as a Senior Manager at Aventis Pharmaceuticals, Inc. from 1992 to 2004.
Mr. Wiley completed his undergraduate degree at The Pennsylvania State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PORTAGE BIOTECH INC
-.--% | 31-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Brian Wiley
| Bedrijven | Functie | Begin |
|---|---|---|
| PORTAGE BIOTECH INC. | Corporate Officer/Principal | 15-02-2022 |
| APREA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2023 |
| Boston Bioconsulting LLC | Founder | 01-08-2018 |
Eerdere bekende functies van Brian Wiley
| Bedrijven | Functie | Einde |
|---|---|---|
| LUMOS PHARMA, INC. | Corporate Officer/Principal | 27-07-2018 |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Sales & Marketing | 26-04-2011 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01-01-2004 |
| CELGENE | Sales & Marketing | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Opleiding van Brian Wiley
| The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PORTAGE BIOTECH INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Gloucester Pharmaceuticals, Inc.
Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Boston Bioconsulting LLC |
